NURECA

Nureca Share Price

₹253.00 0.00 (0.00%)

19 May, 2025 13:28

SIP TrendupStart SIP in NURECA

Start SIP

Performance

  • Low
  • ₹253
  • High
  • ₹253
  • 52 Week Low
  • ₹204
  • 52 Week High
  • ₹448
  • Open Price₹0
  • Previous Close₹253
  • Volume1,035

Investment Returns

  • Over 1 Month + 1.95%
  • Over 3 Month -2.75%
  • Over 6 Month -8.33%
  • Over 1 Year -6.85%
SIP Lightning

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 299.1
  • PEG Ratio
  • 2
  • Market Cap Cr
  • 253
  • P/B Ratio
  • 1.3
  • Average True Range
  • 6.54
  • EPS
  • 0.85
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.86
  • RSI
  • 61.61
  • MFI
  • 89.47

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹253.00
0 (0%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹239.86
  • 50 Day
  • ₹242.91
  • 100 Day
  • ₹257.44
  • 200 Day
  • ₹277.17

Resistance and Support

254.39 Pivot Speed
  • R3 259.93
  • R2 258.55
  • R1 255.77
  • S1 251.61
  • S2 250.23
  • S3 247.45

What's your outlook on Nureca?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 109.66 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 9% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-05 Audited Results
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results
2024-08-05 Quarterly Results
2024-05-15 Audited Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View More

Nureca F&O

Nureca Shareholding Pattern

64.3%
1.07%
32.39%
2.24%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹253 As on 19 May, 2025 | 13:14

The Market Cap of Nureca is ₹253 Cr As on 19 May, 2025 | 13:14

The P/E ratio of Nureca is 299.1 As on 19 May, 2025 | 13:14

The PB ratio of Nureca is 1.3 As on 19 May, 2025 | 13:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23